Dynamics of prices and consumption of anticancer drugs in Russia after their generics and biosimilars became available
Since generics and biosimilars have entered the Russian market of medications, there are new trends in the general picture of drug prices and consumption. In the present study, we analyze these trends to enable the prediction of possible savings or redistribution of funds in the area of anticancer d...
Saved in:
| Main Authors: | F. V. Gorkavenko, A. V. Nikitina, E. S. Saibel’, M. V. Avksent’eva, M. V. Sura, D. V. Fedyaev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2019-07-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/292 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Optimization of drug supply for patients with malignant neoplasms in a region of the Russian Federation
by: A. V. Nikitina, et al.
Published: (2020-02-01) -
Generic giants to biotech frontiers: mapping India’s pharma trajectory—part I
by: Prasanta Kumar Ghosh
Published: (2025-04-01) -
Generics and the specific features of their regulation
by: E. A. Ushkalova, et al.
Published: (2016-11-01) -
TREATMENT OF OSTEOPOROSIS: CLINICAL EXPERIENCE IN USING A GENERIC DRU
by: Nataliya Vladimirovna Toroptsova, et al.
Published: (2011-03-01) -
ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)